Management ChangeSep 1, 2026, 07:23 AM
AstraZeneca Appoints Wan Ling Martello as Non-Executive Director
AI Summary
AstraZeneca PLC announced the appointment of Wan Ling Martello as a Non-Executive Director, effective September 1, 2026. She will also become a member of the Audit Committee. Martello brings significant international experience from her executive leadership roles and board positions at various global businesses, particularly in consumer products and retail industries, with expertise in finance and digital transformation.
Key Highlights
- Wan Ling Martello appointed as Non-Executive Director of AstraZeneca PLC, effective September 1, 2026.
- Wan Ling Martello will also join the Audit Committee upon her appointment to the Board.
- Wan Ling Martello brings extensive international experience from executive leadership roles and board positions at global companies.
- Her expertise includes CFO roles, digital transformation, and B2C technology-enabled business models.
Price Impact
More from AZN